Managing dysfunctional central venous access devices: a practical approach to urokinase thrombolysis

Area of Science:

• Medical Devices
• Vascular Access
• Pharmacology

Background:

• Tunnelled central venous access devices (CVADs) are crucial for treatments like haemodialysis, chemotherapy, and blood product administration.
• Thrombosis and infection are frequent complications of CVADs, potentially leading to severe adverse patient outcomes.
• Current urokinase dosing regimens for CVAD thrombosis management show significant national variation, raising clinical concerns.

Purpose of the Study:

• To address the issue of variable urokinase dosing for suspected CVAD thrombosis.
• To provide standardized guidance for managing CVAD thrombosis using urokinase.
• To develop and audit two algorithms for urokinase intervention in renal and non-renal dysfunctional CVADs.

Main Methods:

• Development of two distinct algorithms for urokinase administration based on renal function.
• Prospective audit of intervention outcomes following the implementation of the developed algorithms.
• Focus Group initiative to address clinical concerns regarding dose regimen variations.

Main Results:

• The study aimed to standardize urokinase use for CVAD thrombosis.
• Algorithms were developed to guide treatment in specific patient populations (renal vs. non-renal dysfunction).
• Prospective audit was planned to evaluate the effectiveness of the new guidance.

Conclusions:

• Standardized guidance is needed to manage urokinase dosing for CVAD thrombosis.
• The developed algorithms offer a framework for consistent and effective treatment.
• Further auditing is essential to confirm the impact of these interventions on patient outcomes.